一项针对晚期肺癌患者的研究显示，早晨时段接受免疫化疗可显著延长生存时间。香港医学专家表示，这一发现为优化治疗时机提供了可能性，但需进一步研究。该研究由湖南癌症医院主导，并获香港中文大学医学系支持。
晚期肺癌患者若在上午时段接受免疫化疗，治疗效果更佳，一项新研究揭示了这一发现。该研究针对非小细胞肺癌患者，比较了不同时段的治疗效果，结果显示，上午3点前施用免疫化疗，几乎将从治疗开始到疾病进展的时间（无进展生存期）延长了一倍，同时将中位总生存期提高了近70%。
这项随机对照研究是首次证明晨间与午后输注免疫化疗的差异，由湖南癌症医院学者主导，并在《自然医学》杂志上发表。香港中文大学临床肿瘤学系主任、研究联合通讯作者莫树锦教授于周五表示：“这一发现极具鼓舞性，仅通过简单调整治疗时机，即可提升疗效并改善生存率，而无需额外成本给患者或医疗系统带来负担。”
莫教授强调，虽然结果令人振奋，但仍需更多研究来验证和推广这一优化策略。该研究为肺癌治疗带来了新希望，尤其是在免疫疗法日益重要的背景下。
由 AI 报道 AI 生成的图像 事实核查
More than 20 years after a small Duke-led clinical trial tested an experimental breast cancer vaccine, Duke Health says all participating women are still alive—an outcome researchers describe as unusual for metastatic disease. Follow-up analyses found long-lived immune cells marked by CD27, and mouse experiments suggest that stimulating CD27 can boost vaccine-driven tumor control.
A randomized trial shows that administering cancer immunotherapy before 3pm can nearly double survival time for patients with non-small cell lung cancer. Researchers found significant benefits from aligning treatment with circadian rhythms during the initial cycles. This marks the strongest evidence yet for chronotherapy in oncology.
由 AI 报道
New research indicates that severe cases of COVID-19 or influenza can alter lung immune cells, potentially increasing cancer risk months or years afterward. The study, conducted by scientists at the University of Virginia, highlights the role of chronic inflammation in this process and emphasizes vaccination as a preventive measure. Findings suggest closer monitoring for affected patients to enable early detection.
Research indicates that inducing labor between 3am and 9am aligns with natural circadian rhythms, potentially reducing labor duration and the need for emergency Caesarean sections. This approach, based on a study of over 3,000 cases in Michigan, offers a simple way to improve outcomes for mothers and babies without added risks. Experts suggest prioritizing first-time mothers and those with higher body mass index for these timings.
由 AI 报道
Scientists from ITQB NOVA and the Portuguese Institute of Oncology have started the BRIDGE project to uncover how aggressive breast cancer evades the immune system. The initiative seeks biomarkers for better prediction of disease progression and personalized treatments. Funded with up to €75,000, the two-year effort uses patient samples to validate lab findings.
Scientists have developed a compound called Mic-628 that advances the body's internal clock, potentially easing jet lag. In tests on mice, a single dose reduced adjustment time to a shifted schedule from seven days to four. The discovery targets a key protein to synchronize rhythms across the body.
由 AI 报道
Researchers in Japan have uncovered how cancer cells use tiny vesicles to spread the immune-suppressing protein PD-L1, explaining why immunotherapy often fails. A protein called UBL3 directs this process, but common statins can disrupt it, potentially boosting treatment effectiveness. The findings, from patient samples and lab tests, suggest a simple way to improve outcomes for lung cancer patients.